We are live on ! Find out more
ENTXW

Entera Bio Ltd. Warrant

Delisted

ENTXW was delisted on the 27th of June, 2023.

2 hedge funds and large institutions have $6K invested in Entera Bio Ltd. Warrant in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 22 (0)

57% less capital invested

Capital invested by funds: $14K → $6K (-$8K)

Holders
2
Holders Change
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
$129K
Puts
Net Calls
+$129K
Net Calls Change
-$150K

Top Buyers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
+$54

Top Sellers

No sellers this quarter

ENTXW Hedge Fund Activity: Q2 2019 in Review

2 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q2 2019, worth a combined $6K — down 57% from $14K a quarter earlier.

Fund positioning in ENTXW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Worth Venture Partners, adding an estimated $54.

  • 2 institutional investors held Entera Bio Ltd. Warrant (ENTXW) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $6K of Entera Bio Ltd. Warrant stock for Q2 2019, down 57% quarter-over-quarter.
  • 0 funds opened new Entera Bio Ltd. Warrant positions in Q2 2019 and 0 closed out.
  • The largest Entera Bio Ltd. Warrant buyer in Q2 2019 was Worth Venture Partners, an estimated $54 added.

Based on aggregated 13F filings for Q2 2019.